BCAX
Bicara Therapeutics·NASDAQ
--
--(--)
--
--(--)
BCAX fundamentals
Bicara Therapeutics (BCAX) released its earnings on Nov 10, 2025: revenue was 0 (YoY 0.00%), beat estimates; EPS was -0.67 (YoY +58.13%), missed estimates.
Revenue / YoY
0
0.00%
EPS / YoY
-0.67
+58.13%
Report date
Nov 10, 2025
EPS
Revenue
Revenue & Expenses
Key Indicators
Bicara Therapeutics (BCAX) key financial stats and ratios, covering profitability, financial health, and leverage.
Bicara Therapeutics (BCAX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Bicara Therapeutics (BCAX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Bicara Therapeutics (BCAX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Bicara Therapeutics (BCAX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Bicara Therapeutics (BCAX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is the market's earnings forecast for Bicara Therapeutics next quarter?What factors drove the changes in Bicara Therapeutics's revenue and profit?What does Bicara Therapeutics do and what are its main business segments?What were the key takeaways from Bicara Therapeutics's earnings call?Did Bicara Therapeutics beat or miss consensus estimates last quarter?What is Bicara Therapeutics's latest dividend and current dividend yield?What guidance did Bicara Therapeutics's management provide for the next earnings period?What were the key takeaways from Bicara Therapeutics’s earnings call?
